Salmeterol/Fluticasonpropionat Devatis

Medicinal product

(Invented) name

Salmeterol/Fluticasonpropionat Devatis

Active substance (s)

Salmeterolis/Flutikazono propionatas

Strength

25 µg/125 µg/dozėje

Pharmaceutical form

suslėgtoji įkvepiamoji suspensija

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03AK06, Salmeterol and fluticasone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-04-20

Date of renewal

Documents

3325_3326_Salmeterol Fluticasonpropionat Devatis_PZ_2026-04-20.docx

3325_3326_Salmeterol Fluticasonpropionat Devatis_PL_2026-04-20.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Salmeterolis	25 µg
Flutikazono propionatas	125 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120671	106778	1106778	slėginė talpyklė	120 dozių N1		Receptinis	LT/L/26/3325/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-04-20	Registruotas